2nd Edition of International Conference on Gastroenterology
September 24-26, 2026, London,UK
Gastrointestinal Interventional Therapy and Evidence-Based Medicine
Non-invasive or minimally invasive procedures can be used to diagnose and treat diseases and disorders of the gastrointestinal (GI) tract. Interventional gastroenterologists evaluate a patient's symptoms, medical history, blood tests, and imaging records to form an opinion and treatment plan, which may include the use of specialised endoscopic procedures. These nonsurgical methods can help patients avoid surgery and recover faster.
"The conscious, explicit, and prudent use of current best evidence in making decisions regarding the care of individual patients" is what evidence-based medicine (EBM) is defined as. The goal of EBM is to use the clinician's experience, the patient's values, and the best available scientific evidence to guide clinical care decisions.
Gilles R G Monif
University of Florida, United States
Tracy E Hill
Ph.D. & Associates LLC, United States
John Andrew Sutton
Gastria Ltd, United Kingdom
Venturi Sebastiano
AUSL-ROMAGNA, Italy
Yaffa Machnes
Bar-Ilan University, Israel
Jose Luis Braga de Aquino
Pontifical Catholic University of Campinas, Brazil
Youcun Qian
Shanghai Institute of Nutrition and Health, ChinaSubmit your abstract Today
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China